In 2015, 3 independent meta-analyses raised concerns about digoxin therapy being
associated with an increased mortality risk in patients with atrial fibrillation (AF) and with …

Atrial fibrillation (AF) is the most common dysrhythmia encountered in the United States.
Symptoms may be similar to those of other cardiac conditions, which can delay the timely …

BACKGROUND Since 2010, the European Society of Cardiology has extended prescription
criteria for oral antithrombotic therapy (OAT) in atrial fibrillation (AF). Direct oral …

Background The impact of atrial fibrillation (AF) on mortality of patients with heart failure (HF)
has been established. Nevertheless, the effect of some factors in mortality, such as digoxin …

Materials and Methods: We conducted a cross-sectional study of all adults aged 18 years
and above, who presented at the AKTH, Kano, and were hospitalised for HF. Those who …

Once a routine part of atrial fibrillation (AF) management, digoxin use has declined. Likely
hastening this decline are findings from several studies and systematic reviews identifying a …

Guidelines recommend angiotensin-converting enzyme inhibitors (ACEi) and angiotensin II
receptor blockers (ARB) for treatment of heart failure with reduced ejection fraction (HFrEF) …

Introduction–Heart failure (HF) and atrial fibrillation (AF) coincide in many patients. The bond
between these two conditions is sealed by the shared similar risk factors and common …

Results: Out of the 30 HF patients with AF studied, 17 (56.7%) died within the period of
follow-up. In bivariate analysis, we found mortality among patients with AF was associated …

Esta tesis describe: 1. Incidencia y mortalidad en pacientes con insuficiencia cardiaca, así
como la utilización de recursos en atención primaria luego del diagnóstico. Periodo entre …